Boenning & Scattergood’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $223K | Sell |
3,744
-525
| -12% | -$31.3K | 0.04% | 367 |
|
|
2022
Q3 | $263K | Hold |
4,269
| – | – | 0.05% | 309 |
|
|
2022
Q2 | $264K | Buy |
4,269
+525
| +14% | +$32.5K | 0.05% | 313 |
|
|
2022
Q1 | $223K | Sell |
3,744
-5,555
| -60% | -$331K | 0.04% | 367 |
|
|
2021
Q4 | $675K | Sell |
9,299
-1,670
| -15% | -$121K | 0.11% | 212 |
|
|
2021
Q3 | $766K | Buy |
10,969
+539
| +5% | +$37.6K | 0.13% | 182 |
|
|
2021
Q2 | $718K | Sell |
10,430
-14,965
| -59% | -$1.03M | 0.13% | 182 |
|
|
2021
Q1 | $1.64M | Buy |
25,395
+14,993
| +144% | +$969K | 0.31% | 90 |
|
|
2020
Q4 | $606K | Sell |
10,402
-5,825
| -36% | -$339K | 0.13% | 177 |
|
|
2020
Q3 | $1.03M | Buy |
16,227
+6,800
| +72% | +$430K | 0.25% | 103 |
|
|
2020
Q2 | $725K | Sell |
9,427
-17,254
| -65% | -$1.33M | 0.19% | 126 |
|
|
2020
Q1 | $2M | Sell |
26,681
-777
| -3% | -$58.1K | 0.69% | 36 |
|
|
2019
Q4 | $1.78M | Buy |
27,458
+4,355
| +19% | +$283K | 0.46% | 54 |
|
|
2019
Q3 | $1.46M | Sell |
23,103
-1,070
| -4% | -$67.8K | 0.42% | 62 |
|
|
2019
Q2 | $1.63M | Sell |
24,173
-4,257
| -15% | -$288K | 0.48% | 58 |
|
|
2019
Q1 | $1.85M | Buy |
28,430
+8,254
| +41% | +$537K | 0.55% | 47 |
|
|
2018
Q4 | $1.26M | Buy |
20,176
+180
| +0.9% | +$11.3K | 0.44% | 58 |
|
|
2018
Q3 | $1.54M | Sell |
19,996
-575
| -3% | -$44.4K | 0.49% | 51 |
|
|
2018
Q2 | $1.46M | Buy |
+20,571
| New | +$1.46M | 0.48% | 60 |
|